NANTES, FRANCE and KVISTGARD, DENMARK--(Marketwire - June 03, 2008) - BAVARIAN NORDIC (CSE : BAVA) has exercised its option to extend the EBx® embryonic stem cell line research license signed with VIVALIS (NYSE Euronext Paris: VLS) on March 30th, 2007.
